The Art of the Decision

February 17, 2017 | Pamela Youngberg Dickson

Last week we shared a few tips on using data to make better decisions. But let’s face it, everyone makes decisions at one time or another without a formal “data strategy.” Sometimes you have competing priorities and need to chart a course among your options. Sometimes you have a problem that needs solving and you need to decide upon a course of action to address it. Sometimes you just have a good idea and want to try it out.

In our own pharmacies, when we think we have a good idea for, say, increasing adherence or improving employee engagement, we test it out in one store. Tweak it. Rinse, and repeat. The learnings and insights we gain get booted over to us at Smart-Fill—like those in our eBook on implementing a med sync program—and we share them with you.

Continue reading →

The Weekly Roundup

February 11, 2017 | Pamela Youngberg Dickson

There have been a lot of brand makeovers underway in pharma lately. While NCPA urges legislators to keep their eyes on the ball, PBMs have been working hard over the last few weeks to clear themselves of responsibility for drug prices by placing the blame on anyone but themselves. Check out the video on transparency in this piece from Business Insider. (Notice any stakeholders missing in their analysis?) Meanwhile, on Wall Street, analysts were looking for more guidance on the role of CVS Health’s PBM division this week, which reportedly “exceeded expectations” in the fourth quarter. CVS has also been busy with a CMS report on the role and impact of DIR fees, and the usual commentators are also weighing in on the debate. All the while, drug manufacturers are reshaping public perception to laud the importance of R&D. Have you noticed?

Here are few other stories that might be of interest:


Continue reading →